相关产品推荐更多 >

生物素标记小鼠抗人CD42b抗体 | Mouse Anti-Human CD42b-BIOT
询价
Clarin 2 (CLRN2) Antibody (Biotin)/Clarin 2 (CLRN2) Antibody (Biotin)/Clarin 2 (CLRN2) Antibody (Biotin)
询价
基质金属蛋白酶9 抗体:偶联PerCP|MMP9 Antibody: PerCP
询价
SRC 抗体(pTyr529):偶联Streptavidin|SRC Antibody (pTyr529): Streptavidin
询价
IRGM 抗体:偶联ATTO 655|IRGM Antibody: ATTO 655
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
SARS-CoV-2 S protein RBD containing C-terminal His Tag. The protein was expressed in human 293 cells (HEK293). It contains amino acids Arg 319 - Lys 537.
- 保存条件:
stored in working aliquots at -20℃, stable for up to one year
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
美洲驼
- 应用范围:
E
- 抗体英文名:
SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7]
- 抗体名:
SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7]
- 规格:
0.02mg
【干冰】SARS-CoV-2 (COVID-19) Spike RBD 抗体 [T4P3-B7],SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7],【干冰】SARS-CoV-2 (COVID-19) Spike RBD 抗体 [T4P3-B7],SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7]
产品名称:【干冰】SARS-CoV-2 (COVID-19) Spike RBD 抗体 [T4P3-B7]-SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7]
产品货号:PSI-SD9433-0.02mg
产品规格:0.02mg
背景资料:Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).
保存建议:【干冰】SARS-CoV-2 (COVID-19) Spike RBD 抗体 [T4P3-B7]-SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7] stored in working aliquots at -20℃, stable for up to one year
应用类型:E
点击:【干冰】SARS-CoV-2 (COVID-19) Spike RBD 抗体 [T4P3-B7]-SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B7]查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验日前,北京大学生命科学学院魏文胜课题组在 Cell 杂志上在线发表题为“Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants”的研究论文。 魏文胜团队首先建立了体外高效制备高纯度环状 RNA 的技术平台,针对新型冠状病毒及其变异株,设计了编码新冠病毒刺突蛋白(Spike)受体结构域(RBD)的环状 RNA 疫苗。 该项研究中制备的针对新冠病毒德尔塔变异株的环状 RNA 疫苗(circRNARBD
中科院高福院士课题组 2020 年发表了哪些重要的研究成果?
:Science 9、Science 后再发 Nature!筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后,2020 年 5 月 26 日,高福院士再次联合严景华等人在 Nature 发文:A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两
XBB.1.5 毒株的传播力为何这么强?北大曹云龙团队最新研究揭示相关机制
导读 SARS-CoV-2 变体 BQ.1.1 和 XBB.1 已在全球范围内传播,前期的研究数据表明,这两个变体与大多数 Omicron 突变体相比具有更优越的生长优势。但是,根据最新的消息,另一 SARS-CoV-2 重组亚型 XBB.1.5 在美国感染人数快速增长,已迅速成为美国的优势毒株,预计很快将会超过现有的流行亚型,并且极有可能引发下一波全球 COVID-19 传播。 图片来源:bioRxiv 尽管 XBB.1.5 拥有着高传播性,但是其内在的分子机制目前仍不清楚。2023 年
技术资料暂无技术资料 索取技术资料






